KCT0002581Recruiting未知
Single-arm, open, multi-center, retrospective, pivotal clinical trial to evaluate the Clinical sensitivity and specificity for assistant of Alzheimer’s disease diagnosis of inBloodTM OAß test
PeopleBio0 sites104 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 104
Study Overview
Brief Summary
Single-arm, open, multi-center, retrospective, pivotal clinical trial to evaluate the Clinical sensitivity and specificity for assistant of Alzheimer’s disease diagnosis of inBloodTM OAß test
Study Design
- Study Type
- Interventional Study
Eligibility Criteria
- Ages
- 50(Year) to 90(Year) (—)
- Sex
- All
Inclusion Criteria
- •The subject groups are selected as follows. Alzheimer’s disease patient group must be age of 50~90 male/female diagnosed probable Alzheimer’s disease or definite Alzheimer’s disease according to the NINCDS-ADRDA Alzheimer's Criteria and normal group must be age of 50~90 male/female without diagnosis of dementia.
Exclusion Criteria
- •Judged not to be qualified by the investigator with clinical diagnosis of dementia, encephalopathy, and delirium will be excluded from participation in this trial.
Investigators
Similar Trials
Recruiting
Not Applicable
A Clinical Trial to Evaluate the Safety and Efficacy of IBS Angel in Patients With Pulmonary Artery StenosisPulmonary Artery StenosisNCT04973540Biotyx Medical (Shenzhen) Co., Ltd.82
Unknown
Not Applicable
Investigation of the Glaukos® Trabecular Micro-Bypass System, Model iS3, in Subjects With Refractory GlaucomaGlaucomaNCT03639870Glaukos Corporation65
Completed
Phase 4
A prospective, multicentric, single arm clinical study to evaluate the effect of saroGlitazar on non HDL-ChoLesterol in patIents with Diabetic Dyslipidaemia inadequately controllEd with diet, exeRcise and statin.(SAROGLITAZAR)CTRI/2016/08/007126Dr Upendra Kaul104
Completed
Phase 3
Clinical trial on Ayurvedic product for viral and bacterial infectionsCTRI/2020/07/026434VENKAT PHARMA
Recruiting
Not Applicable
A Clinical Study Evaluating the Safety and Efficacy of ZRMT Regimen in the Treatment of PCNSLPrimary Central Nervous System LymphomaNCT06445257Huai'an First People's Hospital30